Maynard Um
-
-
-
-
-
-
-
Repligen opens third training center in Netherlands facility
-
-
-
-
-
-
-
Halozyme Therapeutics (HALO) PT Raised at TD Cowen; 'One of Our Top Picks for 2026'
-
-
-
-
-
-
-
HSBC Starts Repligen (RGEN) at Buy
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Repligen (RGEN)
-
-
-
-
-
-
-
Repligen (RGEN) PT Lowered to $940 at Truist Securities
-
-
-
-
-
-
-
TD Cowen Issues Stock Conclusions Following Bioproduction Market Survey
-
-
-
-
-
-
-
TD Cowen Starts Repligen (RGEN) at Buy
-
421,116 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

